Novel COVID-19 POC Screening Tool Based on Proprietary Nano-Sensors and ML Techniques

Project Information

NanoScent COVID-19

Grant agreement ID: 961108

DOI

10.3030/961108

Project closed

EC signature date 27 July 2020

Start date 1 August 2020

End date 31 July 2022

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 3 570 333,75

EU contribution

€ 2 499 233,63

Coordinated by

NANOSCENT LTD
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Open Research Data Pilot (1)

Continuous Report on Communication and Commercialization Activities

Documents, reports (2)

Project QA Handbook
Final Report on Communication and Commercialization Activities

Demonstrators, pilots, prototypes (2)

CE mark for IVD Directive 98/79/EC

CE mark for IVD Directive 9879EC

Commercial mobile application

Publications

Peer reviewed articles (1)

Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds

Author(s): Moria Lichtenstein, Sondra Turjerman, Jayant M. Pinto, Orna Barash, Omry Koren
Published in: mSystems, 2021, ISSN 2379-5077
Publisher: American Society for Microbiology
DOI: 10.1128/msystems.00104-21